FDA Inspection 1036897 — SpineFrontier, Inc.
The FDA completed an inspection of SpineFrontier, Inc. on Nov 29, 2017 in Burlington, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 29, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Burlington, MA (United States)